Amarin PLC Financials

AMRN Stock  USD 0.63  0.01  1.56%   
Based on the measurements of operating efficiency obtained from Amarin PLC's historical financial statements, Amarin PLC is not in a good financial situation at this time. It has a very high odds of going through financial crisis in February. At this time, Amarin PLC's Cash is very stable compared to the past year. As of the 24th of January 2025, Non Current Assets Total is likely to grow to about 128.8 M, while Short and Long Term Debt Total is likely to drop about 9.5 M. Key indicators impacting Amarin PLC's financial strength include:
Current ValueLast YearChange From Last Year 10 Year Trend
Current Ratio2.82.52
Significantly Up
Slightly volatile
Investors should never underestimate Amarin PLC's ability to pay suppliers on time, ensure interest payments are not accumulating, and correctly time where and how to reinvest extra cash. Individual investors need to monitor Amarin PLC's cash flow, debt, and profitability to make informed and accurate decisions about investing in Amarin PLC.

Net Income

(55.86 Million)

  
Understanding current and past Amarin PLC Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Amarin PLC's financial statements are interrelated, with each one affecting the others. For example, an increase in Amarin PLC's assets may result in an increase in income on the income statement.

Amarin PLC Stock Summary

Amarin PLC competes with Scilex Holding, Biogen, Gilead Sciences, AstraZeneca PLC, and Sanofi ADR. Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Amarin Corporation plc was incorporated in 1989 and is headquartered in Dublin, Ireland. Amarin Corp operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 560 people.
Specialization
Health Care, Pharmaceuticals, Biotechnology & Life Sciences
InstrumentUSA Stock View All
ExchangeNASDAQ Exchange
ISINUS0231112063
CUSIP023111206 023111107 297645301 297645202
LocationIreland
Business AddressIconic Offices, The
SectorBiotechnology
IndustryHealth Care
BenchmarkDow Jones Industrial
Websitewww.amarincorp.com
Phone353 0 166 99020
CurrencyUSD - US Dollar

Amarin PLC Key Financial Ratios

Amarin PLC Key Balance Sheet Accounts

202020212022202320242025 (projected)
Total Assets966.0M1.1B886.2M831.7M956.4M1.0B
Other Current Liab198.6M253.1M192.7M204.2M234.8M246.5M
Net Debt(177.8M)(210.9M)(207.7M)(190.5M)(171.5M)(162.9M)
Retained Earnings(1.4B)(1.4B)(1.5B)(1.6B)(1.4B)(1.4B)
Accounts Payable105.9M114.9M64.6M52.8M60.7M63.7M
Cash187.0M219.5M217.7M199.3M229.1M240.6M
Net Receivables154.6M163.7M131.0M133.6M153.6M161.3M
Inventory188.9M234.7M228.7M258.6M297.4M312.3M
Other Current Assets34.9M26.3M20.0M12.1M14.0M14.7M
Total Liab338.5M401.0M290.8M279.6M321.5M337.6M
Total Current Assets879.2M878.7M689.1M725.0M833.7M875.4M
Short Term Debt50.1M169.9M207.5M10.0M11.5M11.0M
Intangible Assets13.8M23.5M21.8M19.3M17.4M13.5M
Common Stock290.1M294.0M299.0M302.8M348.2M365.6M
Other Liab22.3M21.9M21.7M21.4M24.6M32.0M
Other Assets1.1M73.0M121.7M164.1M188.7M198.1M
Net Tangible Assets571.2M613.7M643.6M573.6M659.6M692.6M

Amarin PLC Key Income Statement Accounts

202020212022202320242025 (projected)
Interest Expense2.6M129K15K8K7.2K6.8K
Total Revenue614.1M583.2M369.2M306.9M352.9M370.6M
Gross Profit482.6M461.9M242.5M165.5M190.4M101.4M
Operating Income(19.7M)22.3M(92.3M)(67.6M)(60.8M)(63.9M)
Ebit(14.8M)11.4M(103.7M)(53.9M)(48.5M)(50.9M)
Ebitda(12.7M)14.3M(100.6M)(50.9M)(45.8M)(48.1M)
Cost Of Revenue131.4M121.3M126.7M141.4M162.6M170.7M
Income Before Tax(17.3M)11.3M(103.8M)(53.7M)(48.3M)(50.7M)
Net Income(18M)7.7M(105.8M)(59.1M)(53.2M)(55.9M)
Income Tax Expense745K3.6M2.0M5.4M6.3M6.6M
Research Development39.0M29.3M30.4M22.2M25.6M29.6M
Tax Provision745K3.6M2.0M(5.5M)(5.0M)(4.7M)
Interest Income4.9M1.2M2.8M10.0M9.0M9.5M
Net Interest Income2.3M1.1M2.8M10.0M11.5M12.1M

Amarin PLC Key Cash Accounts

202020212022202320242025 (projected)
Change To Inventory(112.1M)(167.1M)(36.4M)56.3M50.7M53.2M
Change In Cash(457.6M)32.5M(5.2M)(18.4M)(21.2M)(20.1M)
Free Cash Flow(22.0M)(66.5M)(180.7M)6.3M5.7M6.0M
Depreciation2.0M2.9M3.1M3.0M2.7M1.7M
Other Non Cash Items635K1.9M473K(3.7M)(3.3M)(3.2M)
Capital Expenditures252K4.0K599K533K479.7K455.7K
Net Income(18M)7.7M(105.8M)(59.1M)(53.2M)(55.9M)
End Period Cash Flow190.9M223.4M218.2M199.8M229.7M241.2M
Change To Netincome30.9M47.4M38.9M26.7M30.7M32.2M
Investments(377.0M)104.1M175.3M17.7M20.3M21.3M

Amarin Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Amarin PLC's current stock value. Our valuation model uses many indicators to compare Amarin PLC value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Amarin PLC competition to find correlations between indicators driving Amarin PLC's intrinsic value. More Info.
Amarin PLC is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . At this time, Amarin PLC's Return On Equity is very stable compared to the past year. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Amarin PLC's earnings, one of the primary drivers of an investment's value.

Amarin PLC Systematic Risk

Amarin PLC's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Amarin PLC volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was fourteen with a total number of output elements of fourty-seven. The Beta measures systematic risk based on how returns on Amarin PLC correlated with the market. If Beta is less than 0 Amarin PLC generally moves in the opposite direction as compared to the market. If Amarin PLC Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Amarin PLC is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Amarin PLC is generally in the same direction as the market. If Beta > 1 Amarin PLC moves generally in the same direction as, but more than the movement of the benchmark.
Today, most investors in Amarin PLC Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Amarin PLC's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Amarin PLC growth as a starting point in their analysis.

Price Earnings To Growth Ratio

0.12

At this time, Amarin PLC's Price Earnings To Growth Ratio is very stable compared to the past year.

Amarin PLC January 24, 2025 Opportunity Range

Along with financial statement analysis, the daily predictive indicators of Amarin PLC help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Amarin PLC. We use our internally-developed statistical techniques to arrive at the intrinsic value of Amarin PLC based on widely used predictive technical indicators. In general, we focus on analyzing Amarin Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Amarin PLC's daily price indicators and compare them against related drivers.
When determining whether Amarin PLC offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Amarin PLC's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Amarin Plc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Amarin Plc Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Amarin PLC. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
To learn how to invest in Amarin Stock, please use our How to Invest in Amarin PLC guide.
You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Amarin PLC. If investors know Amarin will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Amarin PLC listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.94)
Earnings Share
(0.10)
Revenue Per Share
0.588
Quarterly Revenue Growth
(0.36)
Return On Assets
(0.03)
The market value of Amarin PLC is measured differently than its book value, which is the value of Amarin that is recorded on the company's balance sheet. Investors also form their own opinion of Amarin PLC's value that differs from its market value or its book value, called intrinsic value, which is Amarin PLC's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Amarin PLC's market value can be influenced by many factors that don't directly affect Amarin PLC's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Amarin PLC's value and its price as these two are different measures arrived at by different means. Investors typically determine if Amarin PLC is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Amarin PLC's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.